Consensus review and considerations on TMS to treat depression: A comprehensive Update Endorsed by the National Network of depression Centers, the clinical TMS Society, and the International Federation of clinical Neurophysiology

Dr. Taylor is supported by the Behavior Research Foundation (31081) , NIMH (K23MH129829, R01MH113929, 5R01MH113929) , NIAAA (1R21AA030372) , and a Mass General Brigham Accelerator Grant. Dr. Trapp is supported by grants from the National Institute of Mental Health (1K23MH125145 and R01MH125160) , Magnus Medical, Inc., and the Brain and Behavior Research Foundation (31275) , and received an NNDC Momentum Grant to assist with costs of organizing and publishing this consensus statement. Dr. Lisanby and Dr. Oberman are supported by NIMH ZIAMH002955. Dr. Reti is supported by The Jager Family Foundation. Dr. Youssef is supported by a grant from the American Foundation for Suicide Prevention (DIG-1-134-22) and the National Institute of Mental Health (5R01MH121542) , and by the Michigan Health and Hospital Association (MHA) /LOTUS grant in part for time spent on this effort. Dr. Blumberger receives research support from CIHR, NIMH (R01MH112815; R21MH128815; R01MH1192850) , Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also received in-kind equipment support from Magventure for two investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. Dr. McClintock is supported by grants from the National Institute of Mental Health (R01 MH128691; R01 MH119285; R21 MH130870) . Dr. Singh has received research support from the National Institutes of Health, Patient Centered Outcomes Research Institute, and the Brain and Behavior Research Foundation; she is on a data safety monitoring board for a study funded by the National Institute of Mental Health and on a national scientific advisory board for Skyland Trail. The other authors have no financial conflicts of interest regarding this manuscript.r Inc., and the Brain and Behavior Research Foundation (31275) , and received an NNDC Momentum Grant to assist with costs of organizing and publishing this consensus statement. Dr. Lisanby and Dr. Oberman are supported by NIMH ZIAMH002955. Dr. Reti is supported by The Jager Family Foundation. Dr. Youssef is supported by a grant from the American Foundation for Suicide Prevention (DIG-1-134-22) and the National Institute of Mental Health (5R01MH121542) , and by the Michigan Health and Hospital Association (MHA) /LOTUS grant in part for time spent on this effort. Dr. Blumberger receives research support from CIHR, NIMH (R01MH112815; R21MH128815; R01MH1192850) , Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Family Research Institute. He received research sup-port and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He was the site principal investigator for three sponsor-initiated studies for Brainsway Ltd. He also received in-kind equipment support from Magventure for two investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. Dr. McClintock is supported by grants from the Na-tional Institute of Mental Health (R01 MH128691; R01 MH119285; R21 MH130870) . Dr. Singh has received research support from the National Institutes of Health, Patient Centered Outcomes Research Institute, and the Brain and Behavior Research Foundation; she is on a data safety monitoring board for a study funded by the National Institute of Mental Health and on a national scientific advisory board for Skyland Trail. The other authors have no financial conflicts of interest regarding this manuscript.